CaltechAUTHORS
Published May 1, 2019 | Version Submitted + Published + Supplemental Material
Journal Article Open

Capicua regulates neural stem cell proliferation and lineage specification through control of Ets factors

Creators

  • 1. ROR icon University of Calgary
  • 2. ROR icon University of Toronto
  • 3. ROR icon California Institute of Technology
  • 4. ROR icon Zymeworks (Canada)
  • 5. ROR icon University of California, San Francisco
  • 6. ROR icon Canada's Michael Smith Genome Sciences Centre

Abstract

Capicua (Cic) is a transcriptional repressor mutated in the brain cancer oligodendroglioma. Despite its cancer link, little is known of Cic's function in the brain. We show that nuclear Cic expression is strongest in astrocytes and neurons but weaker in stem cells and oligodendroglial lineage cells. Using a new conditional Cic knockout mouse, we demonstrate that forebrain-specific Cic deletion increases proliferation and self-renewal of neural stem cells. Furthermore, Cic loss biases neural stem cells toward glial lineage selection, expanding the pool of oligodendrocyte precursor cells (OPCs). These proliferation and lineage effects are dependent on de-repression of Ets transcription factors. In patient-derived oligodendroglioma cells, CIC re-expression or ETV5 blockade decreases lineage bias, proliferation, self-renewal, and tumorigenicity. Our results identify Cic as an important regulator of cell fate in neurodevelopment and oligodendroglioma, and suggest that its loss contributes to oligodendroglioma by promoting proliferation and an OPC-like identity via Ets overactivity.

Additional Information

© 2019 The Author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Received 24 May 2017; Accepted 28 March 2019; Published 01 May 2019. Data availability: The authors declare that all data supporting the findings of this study are available within the article and its Supplementary Information files. All biological materials used in this study are available from the corresponding author upon reasonable request. This work was funded by Canadian Institutes for Health Research (J.A.C.), Cancer Research Society (C.S., J.A.C.), Alberta Cancer Foundation (S.T.A., A.D.R., L.F., J.G.C.), Alberta Innovates Health Solutions (J.A.C., C.S.). We thank Edwin Herrenschmidt of Spine Visual Design for original graphic artwork. Author Contributions: Conceptualization, J.A.C., S.T.A.; methodology, J.A.C., C.S., S.T.A.; investigation, S.T.A., A.D.R., R.D., L.F., M.J.C., M.A., W.W., S.O.L., M.D.B.; acquisition, analyses, and interpretation of data, J.A.C., S.T.A., A.D.R.; writing—original draft, J.A.C., S.T.A.; writing—review & editing, J.A.C., C.S., J.G.C., S.M.R., M.A.M., W.W., R.D., S.O.L.; funding acquisition, J.A.C., J.G.C., C.S.; resources, L.A., M.A., C.S; supervision, J.A.C., C.S., J.G.C., S.M.R. The authors declare no competing interests.

Attached Files

Published - s41467-019-09949-6.pdf

Submitted - 335984.full.pdf

Supplemental Material - 41467_2019_9949_MOESM1_ESM.pdf

Supplemental Material - 41467_2019_9949_MOESM2_ESM.pdf

Supplemental Material - 41467_2019_9949_MOESM3_ESM.pdf

Supplemental Material - 41467_2019_9949_MOESM4_ESM.xlsx

Files

335984.full.pdf

Files (110.7 MB)

Name Size
md5:bcab98dd30814f5c0d9ab65c4055346a
41.2 MB Preview Download
md5:02ed47d567feb88b4673bdac1e00e62e
23.7 MB Preview Download
md5:79234857e67c9787fa389b4b3d3f8b86
186.3 kB Preview Download
md5:844b137867935f49622a8ec8b434fafc
2.5 MB Preview Download
md5:a8db6551b7a70164e39b58fcc0a0825d
29.4 MB Download
md5:71193970f996ce8d99af41ee4c2b436b
13.7 MB Preview Download

Additional details

Identifiers

PMCID
PMC6494820
Eprint ID
90003
Resolver ID
CaltechAUTHORS:20180927-114224134

Related works

Describes
10.1101/335984 (DOI)

Funding

Canadian Institutes of Health Research (CIHR)
Cancer Research Society
Alberta Cancer Foundation
Alberta Innovates Health Solutions

Dates

Created
2018-09-27
Created from EPrint's datestamp field
Updated
2023-06-01
Created from EPrint's last_modified field